Cargando…
Acute Toxoplasma Dissemination With Encephalitis in the Era of Biological Therapies
We report the case of a 65-year-old patient with pseudolymphoma who developed acute toxoplasmosis following 6 cycles of rituximab and bendamustine therapy. Acute toxoplasmosis in the setting of biological response modifiers, rather than reactivation, is a unique unreported infection. The patient dev...
Autores principales: | Gharamti, Amal A, Rao, Amy, Pecen, Paula E, Henao-Martínez, Andrés F, Franco-Paredes, Carlos, Montoya, José G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237240/ https://www.ncbi.nlm.nih.gov/pubmed/30460322 http://dx.doi.org/10.1093/ofid/ofy259 |
Ejemplares similares
-
Expanding Spectrum of Toxoplasma gondii: Thymoma and Toxoplasmic Encephalitis
por: Chastain, Daniel B, et al.
Publicado: (2018) -
Anakinra authorized to treat severe coronavirus disease 2019; Sepsis breakthrough or time to reflect?
por: Shapiro, Leland, et al.
Publicado: (2023) -
Symptomatic Acute Toxoplasmosis in Returning Travelers
por: Henao-Martínez, Andrés F, et al.
Publicado: (2018) -
Chasing the Ghost: Hyperinflammation Does Not Cause Sepsis
por: Shapiro, Leland, et al.
Publicado: (2022) -
COVID-19 epidemic in the US—A gateway to screen for tuberculosis, HIV, viral hepatitides, Chagas disease, and other neglected tropical diseases among Hispanics
por: Schultz, Jonathan, et al.
Publicado: (2020)